# NUVL (Nuvalent, Inc.) - SEC EDGAR Financial Statements

> Nuvalent, Inc. reported $1.33B in total assets and a net loss of $450.1M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/NUVL
- Markdown: https://convexityos.com/fundamentals/NUVL.md
- SEC CIK: 0001861560
- Reporting currency: USD
- Latest filing period: March 31, 2026
- Last synced: Nov 20, 2026, 05:10 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001861560&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$438.9M | Operating profit |
| Net Income | FY 2025 | -$450.1M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$5.72 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Mar 31, 2026 | $1.29B | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $307.0M | $217.8M | $113.2M | $63.73M | $35.56M | $15.40M |
| Total Operating Expenses | $414.3M | $280.4M | $149.5M | $86.11M | $45.82M | $16.91M |
| **Operating Income** | -$414.3M | -$280.4M | -$149.5M | -$86.11M | -$45.82M | -$16.91M |
| Interest Income | $44.79M | $38.37M | $23.28M | $4.26M | -- | -- |
| Income Before Tax | -$424.8M | -$260.0M | -$126.2M | -$81.85M | -- | -- |
| Income Tax Expense | $585K | $764K | $0 | $0 | -- | -- |
| **Net Income** | -$425.4M | -$260.8M | -$126.2M | -$81.85M | -$46.34M | -$14.56M |
| Basic EPS | -$5.85 | -$3.93 | -$2.17 | -$1.65 | -$2.13 | -$5.08 |
| **Diluted EPS** | -$5.85 | -$3.93 | -$2.17 | -$1.65 | -$2.13 | -$5.08 |
| Basic Shares Outstanding | 72.7M | 66.4M | 58.2M | 49.7M | 21.8M | 2.9M |
| Diluted Shares Outstanding | 72.7M | 66.4M | 58.2M | 49.7M | 21.8M | 2.9M |

### Income Statement (Quarterly)

| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $83.61M | $67.80M | $83.84M | $80.91M | $74.42M | $69.42M | $60.55M | $49.17M |
| Total Operating Expenses | $119.4M | $102.2M | $112.7M | $104.6M | $94.81M | $86.30M | $76.33M | $65.15M |
| **Operating Income** | -$119.4M | -$102.2M | -$112.7M | -$104.6M | -$94.81M | -$86.30M | -$76.33M | -$65.15M |
| Interest Income | $12.86M | $11.64M | $10.20M | $11.12M | $11.84M | $13.07M | $8.65M | $8.15M |
| Income Before Tax | -$109.1M | -$118.6M | -$122.3M | -$99.51M | -$84.42M | -$74.59M | -$84.31M | -$57.00M |
| Income Tax Expense | $168K | $151K | $132K | $145K | $157K | $171K | $40K | $170K |
| **Net Income** | -$109.3M | -$118.7M | -$122.4M | -$99.65M | -$84.58M | -$74.76M | -$84.34M | -$57.17M |
| Basic EPS | -$1.39 | -- | -$1.70 | -$1.39 | -$1.18 | -- | -$1.28 | -$0.88 |
| **Diluted EPS** | -$1.39 | -- | -$1.70 | -$1.39 | -$1.18 | -- | -$1.28 | -$0.88 |
| Basic Shares Outstanding | 78.7M | -- | 72.1M | 71.8M | 71.6M | -- | 65.7M | 64.6M |
| Diluted Shares Outstanding | 78.7M | -- | 72.1M | 71.8M | 71.6M | -- | 65.7M | 64.6M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $261.7M | $145.7M | $335.4M | $241.8M | $68.53M | $10.33M |
| Short-Term Investments | $1.11B | $972.6M | $384.5M | $230.4M | $219.6M | $0 |
| **Cash & Short-Term Investments** | $1.37B | $1.12B | $719.9M | $472.2M | $288.1M | $10.33M |
| **Total Current Assets** | $1.39B | $1.13B | $726.5M | $478.0M | $290.6M | $10.65M |
| Other Non-Current Assets | $20.28M | $9.30M | $5.90M | $4.47M | $3.20M | -- |
| **Total Non-Current Assets** | $20.28M | $9.30M | $5.90M | $4.47M | $3.20M | $0 |
| **Total Assets** | $1.41B | $1.14B | $732.4M | $482.5M | $293.8M | $10.65M |
| Accounts Payable | $30.16M | $5.22M | $9.27M | $7.20M | $2.89M | $1.25M |
| **Total Current Liabilities** | $91.17M | $54.02M | $31.82M | $19.48M | $8.79M | $4.38M |
| Other Non-Current Liabilities | $35K | $0 | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $73.19M | $17.94M | $0 | $0 | $0 | $2.23M |
| **Total Liabilities** | $164.4M | $71.96M | $31.82M | $19.48M | $8.79M | $6.62M |
| Retained Earnings | -$972.4M | -$547.1M | -$286.3M | -$160.1M | -$78.22M | -$31.89M |
| Accumulated Other Comp. Income | $2.35M | -$59K | $31K | -$494K | -$228K | -- |
| **Total Stockholders' Equity** | $1.25B | $1.07B | $700.6M | $463.0M | $285.0M | -$31.32M |
| Total Equity | $1.25B | $1.07B | $700.6M | $463.0M | $285.0M | -$31.32M |

### Balance Sheet (Quarterly)

| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $159.7M | $261.7M | $115.8M | $127.5M | $120.8M | $145.7M | $369.2M | $77.70M |
| Short-Term Investments | $1.13B | $1.11B | $827.4M | $878.1M | $952.4M | $972.6M | $799.1M | $580.3M |
| **Cash & Short-Term Investments** | $1.29B | $1.37B | $943.1M | $1.01B | $1.07B | $1.12B | $1.17B | $658.0M |
| **Total Current Assets** | $1.31B | $1.39B | $956.9M | $1.02B | $1.09B | $1.13B | $1.18B | $666.3M |
| Other Non-Current Assets | $23.21M | $20.28M | $22.96M | $20.93M | $19.25M | $9.30M | $9.18M | $8.97M |
| **Total Non-Current Assets** | $23.21M | $20.28M | $22.96M | $20.93M | $19.25M | $9.30M | $9.18M | $8.97M |
| **Total Assets** | $1.33B | $1.41B | $979.9M | $1.04B | $1.11B | $1.14B | $1.19B | $675.2M |
| Accounts Payable | $22.14M | $30.16M | $22.01M | $13.34M | $26.16M | $5.22M | $15.93M | $7.40M |
| **Total Current Liabilities** | $81.05M | $91.17M | $89.15M | $75.15M | $75.03M | $54.02M | $51.13M | $38.19M |
| Other Non-Current Liabilities | $0 | $35K | $140K | $244K | $345K | $0 | -- | -- |
| **Total Non-Current Liabilities** | $75.73M | $73.19M | $45.36M | $25.65M | $19.71M | $17.94M | $16.60M | $0 |
| **Total Liabilities** | $156.8M | $164.4M | $134.5M | $100.8M | $94.75M | $71.96M | $67.73M | $38.19M |
| Retained Earnings | -$1.08B | -$972.4M | -$853.7M | -$731.3M | -$631.6M | -$547.1M | -$472.3M | -$387.9M |
| Accumulated Other Comp. Income | -$1.35M | $2.35M | $2.37M | $1.36M | $854K | -$59K | $1.37M | -$1.57M |
| **Total Stockholders' Equity** | $1.17B | $1.25B | $845.4M | $939.7M | $1.01B | $1.07B | $1.12B | $637.0M |
| Total Equity | $1.17B | $1.25B | $845.4M | $939.7M | $1.01B | $1.07B | $1.12B | $637.0M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$425.4M | -$260.8M | -$126.2M | -$81.85M | -$46.34M | -$14.56M |
| Stock-Based Compensation | $86.50M | $60.58M | $25.56M | $10.32M | $3.55M | $729K |
| Change in Payables | $24.60M | -$4.05M | $2.17M | $4.21M | $1.64M | $529K |
| **Operating Cash Flow** | -$275.2M | -$185.1M | -$99.74M | -$64.97M | -$40.00M | -$14.95M |
| Purchases of Investments | -$1.06B | -$1.02B | -$459.5M | -$212.9M | -$221.0M | -- |
| **Investing Cash Flow** | -$124.1M | -$573.5M | -$143.5M | -$10.66M | -$220.0M | -- |
| Common Stock Issued | $515.7M | $570.0M | $338.5M | $250.5M | $177.3M | -- |
| **Financing Cash Flow** | $515.3M | $568.9M | $336.8M | $248.9M | $318.2M | $22.27M |
| **Net Change in Cash** | $116.1M | -$189.7M | $93.58M | $173.3M | $58.19M | $7.32M |

### Cash Flow Statement (Quarterly)

| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$109.3M | -$118.7M | -$122.4M | -$99.65M | -$84.58M | -$74.76M | -$84.34M | -$57.17M |
| Stock-Based Compensation | $28.88M | $21.73M | $22.31M | $22.07M | $20.38M | $16.14M | $15.46M | $15.12M |
| Change in Payables | -$7.69M | $7.81M | $8.67M | -$12.82M | $20.94M | -$10.63M | $8.45M | -$5.99M |
| **Operating Cash Flow** | -$92.40M | -$73.33M | -$70.46M | -$76.60M | -$54.82M | -$62.00M | -$45.82M | -$41.16M |
| Purchases of Investments | -$201.0M | -$444.0M | -$178.5M | -$158.1M | -$277.2M | -$312.5M | -$340.6M | -$88.83M |
| **Investing Cash Flow** | -$19.41M | -$280.9M | $53.97M | $77.48M | $25.42M | -$170.0M | -$212.9M | $16.21M |
| Common Stock Issued | $10.13M | $500.6M | $4.77M | $5.75M | $4.55M | $8.79M | $550.5M | $4.29M |
| **Financing Cash Flow** | $9.80M | $500.3M | $4.77M | $5.75M | $4.55M | $8.49M | $550.3M | $4.14M |
| **Net Change in Cash** | -$102.0M | $146.0M | -$11.72M | $6.63M | -$24.86M | -$223.6M | $291.5M | -$20.82M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -34.1% | -24.4% | -18.0% | -17.7% | -16.3% | -- |
| Return on Assets (ROA) | -30.1% | -22.8% | -17.2% | -17.0% | -15.8% | -136.7% |
| Current Ratio | 15.27x | 20.96x | 22.83x | 24.54x | 33.07x | 2.43x |
| Quick Ratio | 15.05x | 20.70x | 22.62x | 24.24x | 32.79x | 2.36x |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -38.3% | -34.1% | -45.1% | -36.5% | -29.8% | -24.4% | -20.0% | -27.2% |
| Return on Assets (ROA) | -33.8% | -30.1% | -38.9% | -33.0% | -27.2% | -22.8% | -18.9% | -25.7% |
| Current Ratio | 16.14x | 15.27x | 10.73x | 13.57x | 14.48x | 20.96x | 23.07x | 17.44x |
| Quick Ratio | 15.88x | 15.05x | 10.58x | 13.38x | 14.30x | 20.70x | 22.85x | 17.23x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
